
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The complement alternative pathway in health and disease—activation or amplification?
R. A. Harrison, Claire L. Harris, Joshua M. Thurman
Immunological Reviews (2022) Vol. 313, Iss. 1, pp. 6-14
Open Access | Times Cited: 7
R. A. Harrison, Claire L. Harris, Joshua M. Thurman
Immunological Reviews (2022) Vol. 313, Iss. 1, pp. 6-14
Open Access | Times Cited: 7
Showing 7 citing articles:
The role of complement in kidney disease
Vojtěch Petr, Joshua M. Thurman
Nature Reviews Nephrology (2023) Vol. 19, Iss. 12, pp. 771-787
Closed Access | Times Cited: 36
Vojtěch Petr, Joshua M. Thurman
Nature Reviews Nephrology (2023) Vol. 19, Iss. 12, pp. 771-787
Closed Access | Times Cited: 36
Inhibiting the alternative pathway of complement by reducing systemic complement factor B: Randomized, double-blind, placebo-controlled phase 1 studies with Sefaxersen
Michael L. McCaleb, Steven G. Hughes, Tamar R. Grossman, et al.
Immunobiology (2025), pp. 152876-152876
Open Access
Michael L. McCaleb, Steven G. Hughes, Tamar R. Grossman, et al.
Immunobiology (2025), pp. 152876-152876
Open Access
Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection
Stefanos A. Tsiftsoglou, Eleni Gavriilaki, Tasoula Touloumenidou, et al.
Immunobiology (2023) Vol. 228, Iss. 2, pp. 152351-152351
Open Access | Times Cited: 7
Stefanos A. Tsiftsoglou, Eleni Gavriilaki, Tasoula Touloumenidou, et al.
Immunobiology (2023) Vol. 228, Iss. 2, pp. 152351-152351
Open Access | Times Cited: 7
Therapeutic targeting of factor D and MASP3 in complement‐mediated diseases: Lessons learned from mouse studies
Eshagh Mohammadyari, Takashi Miwa, Madhu Golla, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 9
Closed Access | Times Cited: 1
Eshagh Mohammadyari, Takashi Miwa, Madhu Golla, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 9
Closed Access | Times Cited: 1
Heme Interactions as Regulators of the Alternative Pathway Complement Responses and Implications for Heme-Associated Pathologies
Stefanos A. Tsiftsoglou
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 5198-5214
Open Access | Times Cited: 3
Stefanos A. Tsiftsoglou
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 5198-5214
Open Access | Times Cited: 3
A selective alternative pathway complement inhibitor for treatment of paroxysmal nocturnal hemoglobinuria
Hagen Sülzen, Hanna Tulmin, Miroslav Hájek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Hagen Sülzen, Hanna Tulmin, Miroslav Hájek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
A potential bimodal interplay between heme and complement factor H 402H in the deregulation of the complement alternative pathway by SARS-CoV-2
Stefanos A. Tsiftsoglou, Eleni Gavriilaki
Infection Genetics and Evolution (2024) Vol. 126, pp. 105698-105698
Open Access
Stefanos A. Tsiftsoglou, Eleni Gavriilaki
Infection Genetics and Evolution (2024) Vol. 126, pp. 105698-105698
Open Access